Medicare Covers Annual PSA-Based Screenings
In the early 1990s, the annual prostate-specific antigen (PSA) screening test for men 50 years of age and older reduced prostate cancer (PCa) mortality by 50%. Unfortunately, in 2012, based on a flawed PCa screening trial (Screening for Prostate Cancer in Older Patients [PLCO], NCT00002540), […]